| Naslov: | Helicobacter pylori treatment results in Slovenia in the period 2013-2015 as a part of European Registry on Helicobacter pylori management |
|---|
| Avtorji: | ID Tepeš, Bojan (Avtor)
ID Kastelic, Marko (Avtor)
ID Vujasinović, Miroslav (Avtor)
ID Lampic, Polona (Avtor)
ID Šeruga, Maja (Avtor)
ID Brglez Jurecic, Nataša (Avtor)
ID Perez Nyssen, Olga (Avtor)
ID Donday, Maria G. (Avtor)
ID O'Morain, Colm (Avtor)
ID Megraud, Francis (Avtor)
ID Mcnicholl, Adrian G. (Avtor)
ID Gisbert, Javier P. (Avtor) |
|---|
| Datoteke: |  PDF - Predstavitvena datoteka, prenos (302,56 KB)
MD5: 725283A5947443F775708DE9990057FC
|
|---|
| Jezik: | Angleški jezik |
|---|
| Tipologija: | 1.01 - Izvirni znanstveni članek |
|---|
| Organizacija: |  OI - Onkološki inštitut Ljubljana
|
|---|
| Povzetek: | Background. Helicobacter pylori (H. pylori) is the most common chronic bacterial infection in the world affecting over 50% of the world%s population. H. pylori is a grade I carcinogen, responsible for the development of 89 % of noncardia gastric cancers. In the present study we analyzed the data for H. pylori eradication treatments in Slovenia. Patients and methods. Slovenia is a part of the European Registry on Helicobacter pylori Management from the beginning. In seven medical institutions data for H. pylori eradication treatments was collected for 1774 patients from April 16th 2013 to May 15th 2016. For further modified intention to treat (mITT) analysis 1519 patients were eligible and for per protocol (PP) analysis 1346 patients. Results. Patients% dropout was 11.4%. Eradication rate for 7 day triple therapy with proton pump inhibitor (PPI) + Clarithromycin (C) + Amoxicillin (A) was 88.7% PP and 72.0% mITT; for PPI + C + Metronidazole (M) 85.2% PP and 84.4% mITT. Second line 14 day therapy PPI + A + Levofloxacin had 92.3% eradication rate PP and 87.1% mITT. Ten to fourteen day Bismuth quadruple therapy was the therapy in difficult to treat patients. At the end all patients that adhered to prescribed regimens were cured of their H. pylori infection. Conclusions. High dropout rate deserves further analysis. Slovenia is still a country with < 15% H. pylori resistance to clarithromycin, triple therapy with PPI plus two antibiotics reaches PP eradication rate > 85%, but mITT eradication rates are suboptimal. |
|---|
| Ključne besede: | Helicobacter pylori, eradication treatment, European Registry on Helicobacter pylori management, Slovenian results |
|---|
| Status publikacije: | Objavljeno |
|---|
| Verzija publikacije: | Objavljena publikacija |
|---|
| Datum objave: | 01.01.2018 |
|---|
| Založnik: | Association of Radiology and Oncology |
|---|
| Leto izida: | 2018 |
|---|
| Št. strani: | str. 1-6, I |
|---|
| Številčenje: | Vol. 52, no. 1 |
|---|
| Izvor: | Ljubljana |
|---|
| PID: | 20.500.12556/DiRROS-19162  |
|---|
| UDK: | 616.3 |
|---|
| ISSN pri članku: | 1318-2099 |
|---|
| DOI: | 10.1515/raon-2017-0055 |
|---|
| COBISS.SI-ID: | 93860353 |
|---|
| Avtorske pravice: | by Authors |
|---|
| Opomba: | Soavtorji: Marko Kastelic, Miroslav Vujasinovic, Polona Lampic, Maja Seruga, Natasa Brglez Jurecic, Olga P. Nyssen, Maria G. Donday, Colm O'Morain, Francis Megraud, Adrian G McNicholl, Javier P. Gisbert;
|
|---|
| Datum objave v DiRROS: | 02.07.2024 |
|---|
| Število ogledov: | 417 |
|---|
| Število prenosov: | 130 |
|---|
| Metapodatki: |    |
|---|
|
:
|
Kopiraj citat |
|---|
| | | | Objavi na: |  |
|---|
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše
podrobnosti ali sproži prenos. |
